glp 1 japan Real-world use of glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes: A retrospective database study (DEFINE-G) A growing number of women

This review examines the bidirectional interactions between glucoraphanin, sulforaphane, and gut microbiota

Re-analysis of completers: A re-analysis of the same study data that excluded participants who discontinued treatment showed somewhat more encouraging results: 87.5% of those who received alpha-lipoic acid (versus 59.1% of placebo recipients) experienced a modest reduction in hepatic steatosis, and this difference was statistically significant

Babl, N

One possibility is that the decrease in 2-AG is due to GLP-1R-mediated stimulation of PI3K, 82 or inhibition of PTEN, 83 which will decrease the levels of plasma membrane PIP 2 , one of the precursors for 2-AG synthesis

Drugs containing semaglutide, liraglutide, and tirzepatide have received significant attention because many patients experience meaningful weight loss, improved blood sugar control, and other potential health benefits

GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research